---
layout: post
title: "The FDA Puts the Brakes on A Major CRISPR Trial in Humans"
date: 2018-06-02
categories: Science
author: Kristin Houser
tags: [Hemoglobin, Blood, Disease, Sickle-cell disease, Life sciences, Health care, Diseases and disorders, Biology, Health sciences, Medical specialties, Health, Clinical medicine, Medicine]
---




#### Extract
>You&#8217;ve heard it before: CRISPR has the potential to change our lives for the better. But first, we have to give it a chance.
In December, gene-editing company CRISPR Therapeutics announced a partnership with biotech company Vertex to develop CTX001, the world&#8217;s first gene-based treatment for sickle cell disease (SCD). Now, the U.S. Food and Drug Administration (FDA) has denied the companies&#8217; request to move forward with a early-phase trial of CTX001 in adult volunteers, placing a &#8220;clinical hold&#8221; on the application.
According to a CRISPR Therapeutics press release, the FDA has &#8220;certain questions&#8221; it wants resolved before it gives the go-ahead to the human CRISPR study. The company appears to be waiti | tr '
' ' '...



[Visit Link](https://futurism.com/human-crispr-trial-fda-stops/)


